Pseudomonas Across 257 Saturation-Diver Skin Infections
Doctor’s Notes · Life in Motion · Evidence Review
Editorial disclosure: The featured image is an AI-created illustration of a fictional activity, training or occupational setting. It is not a patient, diagnosis, before-and-after image, institutional endorsement or Dr. Arsy #003 treatment result.
Reader question: What did this exact study measure, in whom, with which comparator and timepoint—and which conclusions would go beyond its evidence?
Study snapshot
| Study element | Reported detail |
|---|---|
| Population | 257 Pseudomonas aeruginosa-positive skin infections in operational saturation divers, plus environmental samples from diving systems. |
| Design | Occupational microbiology surveillance with serotyping, growth-inhibition patterns and pulsed-field gel electrophoresis. |
| Comparator | Clinical isolates versus environmental isolates; serotyping versus PFGE discrimination. |
| Timepoint | North Sea operational diving from 1987 through 1995, plus one vessel study during one operational period. |
| Key result | P. aeruginosa was isolated from 257 skin infections. In one vessel study, five DNA profiles were identified among 12 environmental isolates; in two cases infectious genotypes appeared in chamber fresh water weeks before the affected diver arrived. |
| Funding/conflict context | Funding and author-conflict details were not reported in the accessible PubMed abstract. |
What was actually measured?
P. aeruginosa was isolated from 257 skin infections. In one vessel study, five DNA profiles were identified among 12 environmental isolates; in two cases infectious genotypes appeared in chamber fresh water weeks before the affected diver arrived.
The vessel findings demonstrate temporal detection of matching environmental genotypes before two infections. The paper assesses microbiologic linkage rather than infection prevalence among all divers.
The denominator defines the claim. People, visits, infections, episodes, isolates, feet and blisters are different analytic units. A percentage or rate using one unit cannot be silently rewritten as the percentage of people affected.
What the result does not prove
The number of distinct divers and total exposure denominator are not provided in the abstract. Results from one vessel mini-study may not generalize to all saturation systems.
Association and timing do not automatically prove individual causation. Footwear, surfaces, climate, ultraviolet exposure, hygiene, protective equipment, training load, prior conditions, referral patterns and access to care may change an estimate.
A PubMed record is a bibliographic source. PubMed indexing is not NIH endorsement of the authors’ conclusions, this interpretation or any product.
Infection boundary: Moisturization does not eradicate fungi or bacteria, replace culture or other diagnostic testing, or substitute for infection-control and medical treatment.
Keep the condition categories separate
Dryness, friction injury, sunburn, dermatitis, sensitization, fungal disease and bacterial infection are not interchangeable. A moisturizer may support hydration and the moisture barrier, but it does not diagnose infection, prevent ultraviolet injury, replace medical evaluation or substitute for activity-specific prevention.
Persistent spreading redness, drainage, fever, severe pain, rapidly worsening symptoms, a suspected contagious outbreak or major loss of function warrants prompt professional assessment. Clinicians may need microscopy, culture, patch testing, skin-prick testing or other targeted evaluation depending on the question.
Activity details worth documenting
- What surface, footwear, sock, glove, mat, pool, boat, uniform, animal, climate or training load preceded the change?
- Where did the problem begin, and did it change during rest, travel, deployment, competition or a different facility?
- Were towels, clothing, footwear, razors, equipment or showers shared, and how were high-touch surfaces cleaned?
- How often was skin wet, occluded, rubbed, heated, chilled or exposed to sun?
- Did the problem alter sleep, pace, attendance, training, competition, work safety or duty status?
Prevention comes before cosmetic care
Prevention should match the hazard: well-fitted and broken-in equipment, task-appropriate textiles, friction management, clean personal gear, facility hygiene, prompt showering, ultraviolet protection and timely clinical assessment. No single intervention prevents every diagnosis.
Do not share personal skin products during an outbreak and do not test workplace, sport or environmental materials directly on skin. Follow occupational-health, sports-medicine, public-health and facility instructions for contagious or exposure-related conditions.
Primary research and authoritative guidance
- Primary research record: PubMed PMID 9816382
- NIOSH: occupational skin exposure
- NIAMS: atopic dermatitis
- American Academy of Dermatology: eczema skin care
Where Dr. Arsy #003 fits
Dr. Arsy #003 is a cosmetic moisturizer for hydration, moisture-barrier support and dry-skin comfort. This study did not test #003. Its findings do not show that #003 treats, cures or prevents eczema, infection, blisters, sunburn or sensitization; relieves pain or itch; neutralizes environmental exposures; is appropriate for every person; or provides pediatric or 24-hour efficacy.
Continue the evidence series
- Five-Day Blister Progression in 50 Ultramarathon Runners
- Skin-Infection Outcomes in 3,371 Naval Special Warfare Trainees
- Three-and-a-Half-Year Follow-Up of 31 University Judo Athletes
- Foot-Blister Risk Factors in 339 Cadets After a 21-km March
Evidence note: This educational article separates reported findings from interpretation. It is not a diagnosis, treatment recommendation or workplace, sports, military, maritime, animal-exposure or infection-control determination.